PA GOODDOCTOR (01833): Xitong Zhuan has been appointed as an executive director.
Ping An Good Doctor (01833) announced that Mr. Guo Xiaotao has resigned as a non-executive director of the company and as a member of the Nomination and Remuneration Committee; Ms. Fu Xin has resigned as a non-executive director of the company and as a member of the Sustainability Committee; Ms. Cai Fangfang has resigned as a non-executive director of the company and as a member of the Audit and Risk Management Committee; Dr. Zhou Yongjian has resigned as an independent non-executive director of the company and as a member of the Nomination and Remuneration Committee and Chair of the Sustainability Committee; Mr. Zhu Ziyang has resigned as a non-executive director of the company. The aforementioned changes will take effect from August 19, 2026.
PA GOODDOCTOR (01833) announced that Mr. Guo Xiaotao has resigned from his position as a non-executive director and member of the Nomination and Remuneration Committee, Ms. Fu Xin has resigned from her position as a non-executive director and member of the Sustainability Committee, Ms. Cai Fangfang has resigned from her position as a non-executive director and member of the Audit and Risk Management Committee, Dr. Zhou Yongjian has resigned from his position as an independent non-executive director as well as his roles as a member of the Nomination and Remuneration Committee and chair of the Sustainability Committee, and Mr. Zhu Ziyang has resigned from his position as a non-executive director. The aforementioned personnel changes will take effect from August 19, 2026.
Mr. Zhu Yougang has been appointed as a non-executive director, Chairman of the Board, member of the Audit and Risk Management Committee, and member of the Nomination and Remuneration Committee. Mr. Xi Tongzhuan has been appointed as an executive director and member of the Sustainability Committee. Ms. Fan Yanjun has been appointed as a non-executive director and member of the Nomination and Remuneration Committee. Dr. Li Guodong has been appointed as an independent non-executive director, member of the Nomination and Remuneration Committee, and chair of the Sustainability Committee. The aforementioned personnel changes will take effect from August 19, 2026, with an initial term from August 19, 2026, until the time of the first annual general meeting of shareholders of the company held after the appointments, and they will be eligible for re-election at that meeting.
Related Articles

VALUE PARTNERS (00806) announced its interim results, with a profit attributable to shareholders of HKD 188 million, a decrease of 25.5% year-on-year.

TSAKER NE (01986) announced its interim results, with profit attributable to company owners amounting to 94.334 million yuan, an increase of approximately 912.7% year-on-year.

REMEGEN (09995): Purchase financial products
VALUE PARTNERS (00806) announced its interim results, with a profit attributable to shareholders of HKD 188 million, a decrease of 25.5% year-on-year.

TSAKER NE (01986) announced its interim results, with profit attributable to company owners amounting to 94.334 million yuan, an increase of approximately 912.7% year-on-year.

REMEGEN (09995): Purchase financial products

RECOMMEND





